The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Endometriosis, which involves tissue from the uterus, begins with a process known as retrograde menstruation, in which menstrual blood flows back up the fallopian tubes and into the pelvis.